Cagrilintide + Semaglutide (10mg Blend) dosing guide
This is the combination that pharmaceutical companies are racing to bring to market! It pairs semaglutide (like Ozempic) with cagrilintide, which works on a DIFFERENT hunger pathway. Two different 'off switches' for appetite means even better weight loss than either one alone.
Think of it like: Imagine your appetite is like a fire. Semaglutide is like pouring water on it from one direction. Cagrilintide pours water from a completely different direction. By attacking the fire from two angles, you put it out faster and more completely than with just one bucket!
Cagrilintide + Semaglutide is a dual-agonist combination blending an amylin analog (cagrilintide) with a GLP-1 receptor agonist (semaglutide). Clinical trials demonstrate superior weight reduction versus either agent alone, with the combination targeting complementary satiety pathways.
Appetite Regulation
Peptides mimic satiety hormones, reducing hunger signals from the brain.
Quickstart Highlights
- Dosage: 0.25-2.4mg each weekly
- Frequency: Weekly
- Administration: Subcutaneous
- Cycle length: Ongoing
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Weeks 1–4 | 0.25mg each once weekly | 15 units (0.15mL) |
| Weeks 5–8 | 0.5mg each once weekly | 30 units (0.30mL) |
| Weeks 9–12 | 1.0mg each once weekly | 60 units (0.60mL) |
| Weeks 13–16+ | 1.7-2.4mg each once weekly | 102-144 units |
How to mix
Add 3.0mL bacteriostatic water → ~3.33mg/mL total (1.67mg/mL each peptide)
- Draw 3.0mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall.
- Gently swirl until dissolved.
- Label with date and store frozen or refrigerated; use within 30 days.
Syringe Math Reference
- 10mg vial with 3mL BAC water = 3.33 mg/mL total
- Each peptide: 1.67 mg/mL
- 1 unit = 0.01mL ≈ 16.7mcg of each peptide
- 0.25mg each = 15 units
- 0.5mg each = 30 units
- 1.0mg each = 60 units
What you'll need
Blend Vials (10mg)
- 8 weeks (low dose) 1 vial
- 16 weeks (escalating) 4-5 vials
Insulin Syringes (U-100, 1mL)
- 16 weeks 16 syringes
Bacteriostatic Water (10mL)
- 16 weeks 2 bottles
Alcohol Swabs
- 16 weeks 1 × 100-count box
How This Works
This combination targets two complementary pathways for weight loss. Cagrilintide activates amylin receptors to promote satiety and slow gastric emptying. Semaglutide activates GLP-1 receptors to suppress appetite, improve glucose control, and slow gastric emptying. The dual mechanism may produce additive or synergistic effects for weight loss.
Cagrilintide
5mgLong-acting amylin analog that promotes satiety and slows gastric emptying
Semaglutide
5mgGLP-1 receptor agonist for appetite suppression and glucose control
Mechanism of Action
How Cagrilintide Works in Your Body
Peptide Administered
Enters bloodstream and travels to target receptors
Brain Signaling
Binds to GLP-1 receptors in the hypothalamus
Appetite Reduced
Signals satiety — you feel full sooner
Fat Metabolism
Body shifts to burning stored fat for energy
Benefits & Side Effects
Potential Benefits
- Superior weight loss vs monotherapy
- Dual satiety pathway activation
- Enhanced appetite suppression
- Improved glucose control
- Slowed gastric emptying
Potential Side Effects
- Nausea (common, especially during titration)
- Vomiting
- Diarrhea or constipation
- Decreased appetite (intended effect)
- Injection site reactions
How to store it
- Lyophilized: Freeze at −20°C (−4°F).
- Reconstituted: Refrigerate at 2–8°C; use within 30 days.
- Avoid freeze–thaw cycles.
Good to know
- Combination targets complementary satiety pathways.
- Clinical trials show superior weight loss vs either agent alone.
- Gradual titration over 16+ weeks essential.
- GI side effects common during titration.
- Similar to CagriSema (Novo Nordisk development).
Community Insights
Summarised from 2 sourcesCagrilintide + Semaglutide is a dual-agonist combination blending an amylin analog (cagrilintide) with a GLP-1 receptor agonist (semaglutide). Clinical trials demonstrate superior weight reduction versus either agent alone, with the combination targeting complementary satiety pathways. Similar to Ca
Common Dosages Reported
- 0.25-2.4mg each weekly Weekly
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
Enhanced Weight Loss compared to Tirzepatide
A user shared their success with a Cagrilintide and Semaglutide blend (5mg/5mg), noting that it was more effective for weight loss than using Tirzepatide alone. They reported that the combination provided excellent results and expressed satisfaction with the high quality of the product from their specific vendor.
Cagri/Sema for Appetite Suppression and Maintenance
A user discussed utilizing a combination of peptides, including Cagrilintide and Semaglutide, specifically for the maintenance phase of weight loss. They noted that this combination is highly effective at eliminating 'food noise' and preventing grazing behaviors.
Stacking Cagri and Sema to Avoid Fatigue
A commenter suggested that for those struggling with the fatigue often caused by Tirzepatide, a stack of Cagrilintide and Semaglutide can be a potent alternative for appetite suppression. They highlighted that while effective for weight management, users should be mindful of how GLP-1 agonists might interact with the absorption of other medications like ADHD stimulants.
No discussion yet — be the first.
No notes yet — be the first.